Abstract P76  Table 1: appropriateness, success and contraindication rates for patients with and without proformas

	Successfully weaned from NIV	Appropriate for NIV trial	No of patients with contraindications started on NIV
Patients with proforma(n = 46)	30 (65%)	32 (70%)	8 (17%)
Patients without proforma(n = 19)	5 (26%)	3 (21%)	12 (63%)